BOSTONBIOHealthcare Service Provider
Boston Bio Systems Ltd — Balance Sheet
₹8.29
-4.93%
Boston Bio Systems Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 0.70 Cr | 0.70 Cr | 0.70 Cr | 0.70 Cr | — |
| Share Issued | 0.70 Cr | 0.70 Cr | 0.70 Cr | 0.70 Cr | — |
| Net Debt | 5.40 Cr | 0.81 Cr | 0.81 Cr | 0.81 Cr | — |
| Total Debt | 5.44 Cr | 0.87 Cr | 0.87 Cr | 0.87 Cr | — |
| Tangible Book Value | 5.90 Cr | 6.45 Cr | 6.59 Cr | 6.59 Cr | — |
| Invested Capital | 11.35 Cr | 7.32 Cr | 7.46 Cr | 7.46 Cr | — |
| Working Capital | 4.70 Cr | 0.77 Cr | 0.91 Cr | 0.92 Cr | — |
| Net Tangible Assets | 5.90 Cr | 6.45 Cr | 6.59 Cr | 6.59 Cr | — |
| Capital Lease Obligations | 0.00 | 0.00 | 0.00 | — | — |
| Common Stock Equity | 5.90 Cr | 6.45 Cr | 6.59 Cr | 6.59 Cr | — |
| Total Capitalization | 10.50 Cr | 6.57 Cr | 6.71 Cr | 6.71 Cr | — |
| Total Equity Gross Minority Interest | 5.90 Cr | 6.45 Cr | 6.59 Cr | 6.59 Cr | — |
| Stockholders Equity | 5.90 Cr | 6.45 Cr | 6.59 Cr | 6.59 Cr | — |
| Capital Stock | 7.00 Cr | 7.00 Cr | 7.00 Cr | 7.00 Cr | — |
| Common Stock | 7.00 Cr | 7.00 Cr | 7.00 Cr | 7.00 Cr | — |
| Total Liabilities Net Minority Interest | 9.00 Cr | 4.12 Cr | 3.98 Cr | 3.98 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 4.59 Cr | 0.12 Cr | 0.12 Cr | 0.12 Cr | — |
| Other Non Current Liabilities | 1000.00 | — | — | — | — |
| Non Current Deferred Taxes Liabilities | 0.00 | — | — | — | — |
| Long Term Debt And Capital Lease Obligation | 4.59 Cr | 0.12 Cr | 0.12 Cr | 0.12 Cr | — |
| Long Term Capital Lease Obligation | 0.00 | 0.00 | 0.00 | — | — |
| Long Term Debt | 4.59 Cr | 0.12 Cr | 0.12 Cr | 0.12 Cr | — |
| Current Liabilities | 4.41 Cr | 4.00 Cr | 3.86 Cr | 3.86 Cr | — |
| Current Debt And Capital Lease Obligation | 0.85 Cr | 0.75 Cr | 0.75 Cr | 0.75 Cr | — |
| Current Capital Lease Obligation | 0.00 | 0.00 | 0.00 | — | — |
| Current Debt | 0.85 Cr | 0.75 Cr | 0.75 Cr | 0.75 Cr | — |
| Payables | 3.31 Cr | 3.05 Cr | 3.05 Cr | 3.02 Cr | — |
| Accounts Payable | 3.31 Cr | 3.05 Cr | 3.05 Cr | 2.96 Cr | — |
| Total Assets | 14.90 Cr | 10.57 Cr | 10.57 Cr | 10.57 Cr | — |
| Total Non Current Assets | 5.79 Cr | 5.79 Cr | 5.79 Cr | 5.79 Cr | — |
| Non Current Deferred Taxes Assets | 1000.00 | 1000.00 | 1000.00 | 1121.00 | — |
| Investmentin Financial Assets | 0.00 | — | — | — | — |
| Net PPE | 0.00 | 0.00 | 0.00 | — | — |
| Current Assets | 9.11 Cr | 4.77 Cr | 4.77 Cr | 4.78 Cr | — |
| Other Current Assets | 6.02 Cr | -1000.00 | -1000.00 | 0.75 Cr | — |
| Inventory | 0.14 Cr | 0.14 Cr | 0.14 Cr | 0.14 Cr | — |
| Taxes Receivable | 0.00 | 0.02 Cr | 0.02 Cr | 0.02 Cr | — |
| Accounts Receivable | 2.88 Cr | 2.88 Cr | 2.88 Cr | 2.88 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 0.07 Cr | 0.05 Cr | 0.05 Cr | 0.05 Cr | — |
| Other Short Term Investments | 0.03 Cr | — | — | — | — |
| Cash And Cash Equivalents | 0.04 Cr | 0.05 Cr | 0.05 Cr | 0.05 Cr | — |
| Retained Earnings | — | -0.55 Cr | -0.41 Cr | -0.41 Cr | -0.41 Cr |
| Additional Paid In Capital | — | 0.00 | 0.00 | — | — |
| Other Payable | — | 0.20 Cr | 0.06 Cr | 0.06 Cr | 0.06 Cr |
| Total Tax Payable | — | 0.00 | 0.00 | — | — |
| Non Current Prepaid Assets | — | 5.79 Cr | 5.79 Cr | 5.79 Cr | 5.79 Cr |
| Accumulated Depreciation | — | 0.00 | 0.00 | — | — |
| Gross PPE | — | 0.00 | 0.00 | — | — |
| Machinery Furniture Equipment | — | 0.00 | 0.00 | — | — |
| Buildings And Improvements | — | 0.00 | 0.00 | — | — |
| Properties | — | 0.00 | 0.00 | — | — |
| Prepaid Assets | — | 0.00 | 0.00 | 0.91 Cr | 0.91 Cr |
| Other Receivables | — | 1.68 Cr | 1.68 Cr | 0.03 Cr | 0.03 Cr |
| Allowance For Doubtful Accounts Receivable | — | 0.00 | 0.00 | — | — |
| Gross Accounts Receivable | — | 2.88 Cr | 2.88 Cr | — | — |
| Cash Financial | — | 0.05 Cr | 0.05 Cr | 0.05 Cr | 0.05 Cr |
| Current Deferred Taxes Liabilities | — | — | 652.00 | 652.00 | 652.00 |
| Restricted Cash | — | — | 25500.00 | 25500.00 | 25500.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Boston Bio Systems Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.